Depression Awareness Monthly
0
  • Home
  • Latest News
  • Depression
Depression Awareness Monthly
Depression Awareness Monthly
  • Home
  • Latest News
  • Depression
Latest News

Sublingual Buprenorphine/Naloxone Tied to More Adverse Dental Outcomes

Doctorslounge
Posted by Doctorslounge
Share on
READ NEXT
APA: Ketamine Noninferior to ECT for Treatment-Resistant Depression

More adverse dental outcomes seen with sublingual buprenorphine/naloxone compared with use of transdermal buprenorphine or oral naltrexone

Read More

Share on
Share on Facebook Share on Twitter Share on Pinterest Share on Email
Doctorslounge
Previous Article Men Face Five to Seven Times Higher Rates of Firearm Deaths Than Women
Next Article Final Exams Don’t Have to Be High Stress for Your Teen

ADVERTISEMENT

ADVERTISEMENT

You Might Also Enjoy

Latest News

Trauma Exposure, Traumatic Stress Common in Adolescents

Latest News

Antidepressants Vary Significantly in Cardiometabolic Effects

Latest News

Potential Mental Health Advantages Found for Transdermal Versus Oral Hormone Therapy

Latest News

Loneliness, Social Isolation Tied to Higher Mortality in Patients With Cancer

Load More
Depression Awareness Monthly
  • Home
  • Latest News
  • Depression

© 2020 - 2021 Powered by eHealthcare Solutions | Privacy Policy

×